Gaspard W, N'Gampolo I, Rivière F, Lefloch H, Margery J, Marotel C, Soler C, Vaylet F. [Mycobacterial pulmonary infection due to Mycobacterium simiae].
Rev Mal Respir 2015;
33:248-52. [PMID:
26282361 DOI:
10.1016/j.rmr.2015.06.005]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2014] [Accepted: 05/05/2015] [Indexed: 10/23/2022]
Abstract
INTRODUCTION
Mycobacterium simiae pulmonary infections remain exceptional in France.
CASE REPORT
We report a case of M. simiae lung infection and a 10-year follow-up in a non-immunocompromised host.
CONCLUSION
This case emphasizes the difficulties of choosing the appropriate drugs and their side effects in the absence of any existing gold standard.
Collapse